AstraZeneca's partner FibroGen gets Chinese approval for CKD treatment roxadustat
How Much Thrombotic Risk Is OK for Novel CKD Anemia Drug? | MedPage Today
Eskayef Pharmaceuticals Ltd. | Brand | Oroxat
The prolyl hydroxylase inhibitor roxadustat: Paradigm in drug discovery and prospects for clinical application beyond anemia - ScienceDirect
Astellas' EVRENZO▽™ (roxadustat) to be reimbursed under the High Tech Drugs Scheme in Ireland For Adults With Symptomatic Anaemia Associated With Chronic Kidney Disease (CKD) - Irish Pharmacy News